Susanna Gallo

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

Journal: Cancer

Published: February 19, 2026

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.

Journal: Cancer

Published: July 19, 2022

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers.

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers.

Journal: British journal of haematology

Published: July 01, 2022

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

Journal: Journal of clinical medicine

Published: January 22, 2021

Melanoma Brain Metastases in the Era of Target Therapies: An Overview.

Melanoma Brain Metastases in the Era of Target Therapies: An Overview.

Journal: Cancers

Published: May 28, 2020

Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibody.

Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibody.

Journal: Veterinary immunology and immunopathology

Published: May 14, 2018

BRAF-inhibitors can exert control of disease in BRAF T599I mutated melanoma: a case report.

BRAF-inhibitors can exert control of disease in BRAF T599I mutated melanoma: a case report.

Journal: Melanoma research

Published: December 13, 2017

Treating breast cancer with cell-based approaches: an overview.

Treating breast cancer with cell-based approaches: an overview.

Journal: Expert opinion on biological therapy

Published: July 22, 2017

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: September 28, 2016

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 21, 2016

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 25, 2013

Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.

Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: August 16, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026